Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$20.39 0.39 (1.95%)
2/9/2010 4:00 PM

Martek Biosciences Corp. (MATK)

CAPS Rating:
****

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating MATK

Add Stock to Watchlist

What the Community Thinks

Total Members

369 Outperforms
16 Underperforms
 

All-Stars

74 Outperforms
3 Underperforms
 

Wall Street

6 Outperforms
0 Underperforms
 

Members bullish on MATK are also bullish on:

Members bearish on MATK are also bearish on:

Ticker Tags

Defensive (1457), Biotechnology (220), Healthcare (711), Small Cap (1645), Value (1901)
Suggest a tag

Martek Biosciences Corp. At A Glance

Current Price: $20.39
Last Trade Time: 2/9/2010 4:00 PM
Open: $20.14
Previous Close: $20.00
Daily Range: $20.01 - $20.49
52-Week Range: $15.36 - $26.19
Volume: 234,117
Market Cap: $678.38M
P/E Ratio: 16.39
Compare Our Special Broker Offers!

Stock Trends

MATK VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Martek Biosciences Corp. (MATK)

Avatar pwalls01 (21.13) Submitted: 4/24/08 12:32 PM

Develops and commercializes products derived from microalgae, fungi and other microbes. Products are nutritional oils used as ingredients in infant formula and foods, and as ingredients in and encapsulated for use as dietary supplements.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Martek Biosciences Corp. (MATK)

Avatar alexferrari (< 20) Submitted: 10/10/06 9:44 PM

DHA powder is too expensive to be acepted by food manufacturers. DHA oil is not stable enough to be used in most food applications. Martek's oil will perform only as a niche product in some vegetarian foods.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 59 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (MATK)

Avatar Investin1 (49.03) Submitted: 12/29/09 2:22 AM : Underperform Start Price: $19.41 MATK Score: -10.17

DHP derived from algae is more costly to produce than that from fish. The market has already been fully penetrated for DHP, and adult sales show very little in terms of growth prospects for the company. The company many have decent cash flow, but the cash is not headed towards R&D.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MATK)

Avatar unicornhunter7 (96.64) Submitted: 12/21/09 11:04 AM : Outperform Start Price: $18.49 MATK Score: 14.09

The nutritional oils it makes are added to baby formulas, and they are being adopted by more countries. It has signed contracts with companies in Spain and China, and is trying to find uses outside the baby formula markket. I am looking ahead a few years, and like the possibilities.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MATK)

Avatar corycareful (37.28) Submitted: 12/13/09 2:51 PM : Outperform Start Price: $18.02 MATK Score: 17.31

Producing necessary oils in a time of declining fish stocks and increasing interest in vegetarianism.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MATK)

Avatar biofest (< 20) Submitted: 12/06/09 3:09 PM : Outperform Start Price: $17.67 MATK Score: 18.72

Omega 3 from seaweed. Oil from seaweed ?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (MATK)

Avatar TMFConnor (86.19) Submitted: 11/16/09 11:57 AM : Outperform Start Price: $17.67 MATK Score: 18.72

Price/Cash Flow Screener

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 59 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 6 of 6  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCantorFitz 31.61 03/25/09 Outperform NS $17.25+18.20%+33.22%-15.02
TrackNorthlandSe 52.68 03/19/09 Outperform NS $17.88+14.04%+34.76%-20.72
TrackScottBleier 91.98 12/28/07 Outperform 3M $29.37-30.58%-24.14%-6.44
TrackBroadpoint.AmTech 76.97 10/08/07 Outperform NS $30.48-33.10%-27.64%-5.47
TrackNeedham 67.64 09/07/06 Outperform NS $21.91-6.94%-12.10%+5.16
TrackJimCramer < 20 03/10/06 Outperform 3W $33.09-38.38%-10.39%-27.99

Results 1 - 6 of 6  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 937ms